跳至主要内容
临床试验/NCT05821829
NCT05821829招募中不适用

Endovascular Treatment of Primary Common FEmoral Artery atheroSclerotic Disease wiTh IntraVAscular Litothripsy: the FESTIVAL Registry

University of Pisa1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Technical success

研究概览

简要总结

Prospective, nonrandomized, multicenter, national, multidisciplinary, real-world data collection with the aim to evaluate the short-term safety and efficacy of intravascular lithotripsy in the treatment of steno-obstructive disease of the common femoral artery

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with peripheral arterial disease (Rutherford class 3-6)
  • Presence of a steno-obstructive lesion of the common femoral artery (Azema classification 1-3)
  • Possible endovascular treatment of both the iliac axis and/or femoro-distal vessels
  • Possible post-dilatation with plain or drug-coated balloon angioplasty

排除标准

  • Concomitant open surgery (ilio-femoral or femoro-distal bypass)
  • Presence of a steno-obstructive lesion of the common femoral artery in previous open surgery (Azema classification 4)
  • Presence of a steno-obstructive lesion of the common femoral artery after a previous endovascular procedure

结局指标

主要结局

Technical success

时间窗: Intraprocedural

insertion/use of the device after crossing the steno-obstructive lesion and its removal without complications, restoration of vessel patency in the absence of stenosis/acute recoil \>30%, rupture/perforation of the common femoral artery, need for a bailout stenting

Secondary patency

时间窗: 1 month / 6 months / 1 year

patency of the treated vessel after occlusione and treatment by surgical or endovascular means

Clinical success

时间窗: Intraprocedural / 1 month

absence of intraprocedural complications including distal embolization and improvement of at least 1 Rutherford class assessed 1 month after the procedure

Primary assisted patency

时间窗: 1 month / 6 months / 1 year

patency of the treated vessel after one or more endovascular reinterventions

Clinically driven freedom from target lesion restenosis (cdTLR)

时间窗: 1 month / 6 months / 1 year

restenosis resulting in vessel occlusion or stenosis with maximum PSV \> 2.5 m/sec

Primary patency

时间窗: 1 month / 6 months / 1 year

patency of the treated vessel in the absence of a restenosis \>30%

次要结局

  • Limb salvage(1 month / 6 months / 1 year)
  • Freedom from any reinterventions(1 month / 6 months / 1 year)
  • Patency of profunda femoris(1 month / 6 months / 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicola Troisi

Associate Professor of Vascular Surgery

University of Pisa

研究点 (1)

Loading locations...

相似试验